Up next

Autoplay

Breast cancer patients who interrupted endocrine therapy to pursue pregnancy did not have worse ...

2 Views • 07/16/23
Share
Embed
administrator
administrator
Subscribers
0

Dr Cristina Saura speaks to ecancer as part of SABCS 2022 about the results of the POSITIVE trial.

She states the primary endpoint of the trial was a breast cancer free interval for patients.

Dr Saura explains the results showed breast cancer patients who interrupted endocrine therapy to pursue pregnancy did not have worse short-term recurrence rates..

Show more
0 Comments sort Sort By
Facebook Comments

Up next

Autoplay